What is the success rate of letrozole in treating metastatic breast cancer and how does its efficacy compare with other treatment options for this advanced stage of the disease?
Lakshya KumarExplorer
What is the success rate of letrozole in treating metastatic breast cancer?
Share
Letrozole has a success rate of around 30-40% in treating hormone-receptor-positive metastatic breast cancer. It is often more effective than tamoxifen for postmenopausal women.
Letrozole shows a success rate of approximately 30-40% for treating metastatic breast cancer and is generally more effective than older anti-estrogens like tamoxifen in postmenopausal women.